While reversing established central nervous system damage is clearly a
difficult task, preventing or limiting ongoing destructive processes
in the brain may be a more achievable goal. The monitoring technology
required to detect clinically significant adverse secondary events has
evolved considerably in the past few years. As a result it has become
evident that such adverse events are common in the head injured patie
nt and that they can have a dramatic effect on outcome. Furthermore, i
t is also becoming clear that these secondary insults are, to a signif
icant degree, preventable, It is likely that simple physiological mane
uvers, such as maintaining the cerebral perfusion pressure, as well as
newer pharmacological agents, will be useful for this purpose. The pa
thophysiology of brain swelling remains unclear and deserves continued
study. This review describes the factors responsible for secondary br
ain injury, some practical ways of identifying and managing them, and
certain newer pharmacological agents that may be valuable in the clini
cal setting.